TQ-B3395

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQ-B3395, covering 2024-09-23 to 2024-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics [Phase 1]